Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Alpelisib(BYL719) CAS:1217486-61-7
Alpelisib(BYL719)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1351 | 100mg | 175.00 | + Add to cart |
|
| R-C-1351 | 200mg | 325.00 | + Add to cart |
|
| R-C-1351 | 500mg | 715.00 | + Add to cart |
|
|
|
||||
Product description
Alpelisib(BYL-719)is a potent,selective, and orally active PI3Kα inhibitor. Alpelisib(BYL-719)shows efficacy in targeting PIK3CA-mutated cancer.Alpelisib (BYL-719)also inhibits p110α/p110γ/p110δ/p110β with IC50s of 5/250/290/1200 nM,respectively.Antineoplastic activity.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---Alpelisib(BYL719) Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
